Company research
Third Harmonic Bio, Inc.
CIK 1923840Updated Sep 27, 2026
Filing activity
Latest filing
50 filings on record · SCHEDULE 13G/A, 4, 15-12G, EFFECT, 8-K, S-8 POS.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 294,608,000Source | 277,711,000Source | 298,675,000Source | 129,164,000Source |
| Property, Plant and Equipment, NetUSD | 130,000Source | 169,000Source | 35,000Source | 0Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 285,063,000Source | 269,070,000Source | 288,877,000Source | 128,280,000Source |
| Assets, CurrentUSD | 290,538,000Source | 272,446,000Source | 292,835,000Source | 129,164,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 5,475,000Source | 3,376,000Source | 3,958,000Source | 884,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,039,000Source | 3,763,000Source | 4,327,000Source | 0Source |
| Other Assets, NoncurrentUSD | 448,000Source | 880,000Source | 1,037,000Source | 0Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 9,458,000Source | 8,626,000Source | 9,607,000Source | 5,686,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 5,000Source | 4,000Source | 4,000Source | 1,000Source |
| Additional Paid in CapitalUSD | 444,834,000Source | 383,301,000Source | 372,460,000Source | 1,534,000Source |
| Retained Earnings (Accumulated Deficit)USD | -159,689,000Source | -114,220,000Source | -83,396,000Source | -48,241,000Source |
| Stockholders' Equity Attributable to ParentUSD | 285,150,000Source | 269,085,000Source | 289,068,000Source | -46,706,000Source |
| Liabilities and EquityUSD | 294,608,000Source | 277,711,000Source | 298,675,000Source | 129,164,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,109,000Source | 5,418,000Source | 5,653,000Source | 5,686,000Source |
| Operating Lease, Liability, CurrentUSD | 859,000Source | 745,000Source | 385,000Source | 0Source |
| Accounts Payable, CurrentUSD | 1,937,000Source | 1,838,000Source | 2,087,000Source | 1,797,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,349,000Source | 3,208,000Source | 3,954,000Source | 0Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 11,086,000Source | 9,577,000Source | 4,751,000Source | 510,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 99,000Source | -249,000Source | 290,000Source | 1,216,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -34,503,000Source | -20,425,000Source | -34,917,000Source | -15,746,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -10,000Source | -169,000Source | -36,000Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 10,000Source | 169,000Source | 36,000Source | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 50,506,000Source | 799,000Source | 195,991,000Source | 135,749,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 15,993,000Source | -19,795,000Source | 161,038,000Source | 120,003,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 285,516,000Source | 269,523,000Source | 289,318,000Source | 128,280,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 11,086,000Source | 9,577,000Source | 4,751,000Source | 510,000Source |
| DepreciationUSD | 49,000Source | 35,000Source | 1,000Source | 0Source |
| General and Administrative ExpenseUSD | 22,372,000Source | 19,990,000Source | 13,301,000Source | 3,256,000Source |
| Net Income (Loss) Attributable to ParentUSD | -45,469,000Source | -30,824,000Source | -35,155,000Source | -29,609,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 45,469,000Source | 30,824,000Source | -35,155,000Source | -29,609,000Source |
| Nonoperating Income (Expense)USD | 13,403,000Source | 13,130,000Source | 2,553,000Source | -10,605,000Source |
| Operating ExpensesUSD | 58,872,000Source | 43,954,000Source | 37,708,000Source | 19,004,000Source |
| Other Nonoperating Income (Expense)USD | -6,000Source | 22,000Source | 2,553,000Source | 5,000Source |
| Proceeds from Issuance of Common StockUSD | 48,668,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 1,838,000Source | 1,264,000Source | 107,000Source | 0Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -58,872,000Source | -43,954,000Source | -37,708,000Source | -19,004,000Source |
| Other Nonoperating Income (Expense)USD | -6,000Source | 22,000Source | 2,553,000Source | 5,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -45,469,000Source | -30,824,000Source | -35,155,000Source | -29,609,000Source |
| Net Income (Loss) Attributable to ParentUSD | -45,469,000Source | -30,824,000Source | -35,155,000Source | -29,609,000Source |
| Earnings Per Share, BasicUSD per share | 1.09Source | 0.78Source | -2.62Source | -7.32Source |
| Earnings Per Share, DilutedUSD per share | 1.09Source | 0.78Source | -2.62Source | -7.32Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 41,730,464Source | 39,645,392Source | 13,426,066Source | 4,043,416Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 41,730,464Source | 39,645,392Source | 13,426,066Source | 4,043,416Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 22,372,000Source | 19,990,000Source | 13,301,000Source | 3,256,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -45,469,000Source | -30,824,000Source | -35,155,000Source | -29,609,000Source |
| Interest Income (Expense), NetUSD | 13,409,000Source | 13,108,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 45,469,000Source | 30,824,000Source | -35,155,000Source | -29,609,000Source |
| Nonoperating Income (Expense)USD | 13,403,000Source | 13,130,000Source | 2,553,000Source | -10,605,000Source |
| Operating ExpensesUSD | 58,872,000Source | 43,954,000Source | 37,708,000Source | 19,004,000Source |
| Research and Development ExpenseUSD | 36,500,000Source | 23,964,000Source | 24,407,000Source | 15,748,000Source |